Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples.
about
Asthma outcomes: biomarkersCharacterizing asthma from a drop of blood using neutrophil chemotaxis.Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis.Galectin-10, a potential biomarker of eosinophilic airway inflammation.Short-term reproducibility of the inflammatory phenotype in different subgroups of adult asthma cohortHeterogeneity of bronchitis in airway diseases in tertiary care clinical practice.Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a studyYear-in-review 2010: asthma, COPD, cystic fibrosis and airway biology.Safe use of long-acting β-agonists: what have we learnt?Untangling asthma phenotypes and endotypes.Recent advances in asthma biomarker research.The transition of sputum inflammatory cell profiles is variable in stable asthma patients.The need to differentiate between adults and children when treating severe asthma.Advanced Role of Neutrophils in Common Respiratory DiseasesNovel approaches to the management of noneosinophilic asthma.Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma.The clinical profile of benralizumab in the management of severe eosinophilic asthma.Relationship between airway neutrophilia and ageing in asthmatics and non-asthmatics.Neutrophilic inflammation in asthma: mechanisms and therapeutic considerations.Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma.Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes.
P2860
Q30425168-84CB7380-AF3A-4E14-BB24-93B53AB446D7Q30577123-8EFA5B50-9FC1-41D4-8744-7C88B6276885Q33693224-4ED42B0D-D99D-48AA-B1CC-84D2DF6E7980Q34374316-94A62197-145A-4573-B653-526D0EB00A4CQ35189410-3D121430-605B-45BF-A691-187245B32184Q35895654-8444C439-4767-408E-AF83-8B86944691FEQ36828893-084F8DDC-47D3-4E40-B8A2-6026EDE26C8EQ37371731-74AAAE14-2C4A-4D94-9956-868FE88BB64EQ37845433-A35B57CC-3F55-4A10-AFDA-068AB85BD277Q37869146-4BEDAA77-CAEB-40EE-989D-74383FE2C9ECQ38010795-6A752B73-5C3E-4826-B59C-0D2C6EDB67D6Q38125948-849765BA-5296-4B7A-AF23-B355375410D5Q38406118-D9425116-D789-41BC-8D01-5C2493156024Q38547303-4254A692-878D-46F1-9551-ECFC5D2948A4Q38739370-23A6414A-770C-47F9-BD18-865B71BB949AQ38756064-477A2FB5-257C-4A18-A340-7F6747CDD64BQ38818964-28745874-A9AC-44D3-9470-849A3725780BQ38822826-D56FAED1-F1B6-4755-9929-8012E2BD6485Q39451762-A43F5228-32AD-4022-A551-F00907FF1954Q40423635-4B43F996-58B7-4CE9-AD9A-AD7F4672B0D9Q40741018-DD881DB8-37D2-4E2F-8776-E2FA87A8D8B3Q45790677-5819B12E-84B8-46F4-A513-DC7EBDDAE23AQ47920475-8DF6B96A-7625-4245-A1D5-E843540BE4C4
P2860
Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Variability of sputum inflamma ...... study using multiple samples.
@en
Variability of sputum inflamma ...... study using multiple samples.
@nl
type
label
Variability of sputum inflamma ...... study using multiple samples.
@en
Variability of sputum inflamma ...... study using multiple samples.
@nl
prefLabel
Variability of sputum inflamma ...... study using multiple samples.
@en
Variability of sputum inflamma ...... study using multiple samples.
@nl
P2093
P921
P1476
Variability of sputum inflamma ...... study using multiple samples.
@en
P2093
Andrea Benedetti
Catherine Lemière
David Préfontaine
James G Martin
Mohammed T Al-Samri
Parameswaran Nair
Ron Olivenstein
P304
1161-1163.e4
P356
10.1016/J.JACI.2010.02.005
P407
P577
2010-04-14T00:00:00Z